BAY-390 |
| Katalog-Nr.GC68735 |
BAY-390 ist ein selektiver, interartübergreifend aktiver TRPA1-Inhibitor, der das Gehirn durchdringen kann. BAY-390 hemmt hTRPA1 FLIPR, hTRPA1 Ephys, rTRPA1 FLIPR und rDRG Ephys mit IC50-Werten von jeweils 16, 82, 63 und 35 nM. BAY-390 kann für die Erforschung von Entzündungen verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2741956-55-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for BAY-390
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for BAY-390
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *